3,3'-dipropyl-2,2'-thiadicarbocyanine has been researched along with sq-23377 in 1 studies
| Studies (3,3'-dipropyl-2,2'-thiadicarbocyanine) | Trials (3,3'-dipropyl-2,2'-thiadicarbocyanine) | Recent Studies (post-2010) (3,3'-dipropyl-2,2'-thiadicarbocyanine) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
|---|---|---|---|---|---|
| 134 | 0 | 12 | 4,385 | 10 | 493 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, CF; Lee, YJ; Su, MJ; Wang, SJ; Yang, TT | 1 |
1 other study(ies) available for 3,3'-dipropyl-2,2'-thiadicarbocyanine and sq-23377
| Article | Year |
|---|---|
Morphine inhibits glutamate exocytosis from rat cerebral cortex nerve terminals (synaptosomes) by reducing Ca2+ influx.
Topics: 4-Aminopyridine; Analgesics, Opioid; Animals; Benzothiazoles; Benzoxazines; Calcium; Calcium Channel Blockers; Carbocyanines; Cerebral Cortex; Dose-Response Relationship, Drug; Exocytosis; Fluorometry; Fura-2; Glutamic Acid; Ionomycin; Ionophores; Male; Membrane Potentials; Morphine; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Synaptosomes | 2004 |